|
US5858358A
(en)
|
1992-04-07 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for selectively stimulating proliferation of T cells
|
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
|
US5523226A
(en)
|
1993-05-14 |
1996-06-04 |
Biotechnology Research And Development Corp. |
Transgenic swine compositions and methods
|
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
|
US7067318B2
(en)
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
|
US6692964B1
(en)
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
|
US5780300A
(en)
|
1995-09-29 |
1998-07-14 |
Yale University |
Manipulation of non-terminally differentiated cells using the notch pathway
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
GB9710807D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
AU749465B2
(en)
|
1997-06-13 |
2002-06-27 |
Japanese Foundation For Cancer Research |
Smad6 and uses thereof
|
|
NZ501276A
(en)
|
1997-07-01 |
2000-10-27 |
Warner Lambert Co |
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders
|
|
US6140081A
(en)
|
1998-10-16 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger binding domains for GNN
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
KR20030032922A
(ko)
|
2000-02-24 |
2003-04-26 |
싸이트 테라피스 인코포레이티드 |
세포의 동시 자극 및 농축
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
JP3811775B2
(ja)
|
2000-07-19 |
2006-08-23 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
４−ヨードフェニルアミノベンズヒドロキサム酸の酸素化エステル
|
|
JP2002060786A
(ja)
|
2000-08-23 |
2002-02-26 |
Kao Corp |
硬質表面用殺菌防汚剤
|
|
US6689744B2
(en)
|
2000-09-22 |
2004-02-10 |
Genentech, Inc. |
Notch receptor agonists and uses
|
|
WO2002059285A1
(en)
|
2000-10-27 |
2002-08-01 |
Fred Hutchinson Cancer Research Center |
Methods for immortalizing cells
|
|
JP2005500061A
(ja)
|
2001-08-20 |
2005-01-06 |
ザ スクリップス リサーチ インスティテュート |
Ｃｎｎについての亜鉛フィンガー結合ドメイン
|
|
EP1456380B1
(en)
|
2001-11-02 |
2012-04-18 |
Giuliani International Limited |
Smad7 inhibitors for the treatment of cns diseases
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
KR100984595B1
(ko)
|
2002-03-13 |
2010-09-30 |
어레이 바이오파마 인크. |
Ｍｅｋ 억제제로서의 ｎ3 알킬화 벤즈이미다졸 유도체
|
|
US7575925B2
(en)
|
2002-12-10 |
2009-08-18 |
Sunnybrook Health Sciences Centre |
Cell preparations comprising cells of the T cell lineage and methods of making and using them
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
CN1905873A
(zh)
|
2003-11-19 |
2007-01-31 |
阵列生物制药公司 |
Mek的杂环抑制剂及其使用方法
|
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
WO2005118788A2
(en)
|
2004-05-27 |
2005-12-15 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
US20070036769A9
(en)
|
2004-06-03 |
2007-02-15 |
Linheng Li |
BMP pathway methods and compositions
|
|
ES2405785T3
(es)
|
2005-05-18 |
2013-06-03 |
Array Biopharma Inc. |
Inhibidores heterocíclicos de MEK y métodos de uso de los mismos
|
|
EP1992360A4
(en)
|
2006-02-01 |
2010-02-17 |
Univ Tokyo |
COMMON USE OF A TGF BETA SIGNAL HEMMER AND AN ANTITUMORAL AGENT
|
|
RU2425876C2
(ru)
|
2006-03-24 |
2011-08-10 |
Чилдрен'З Медикал Сентер Корпорейшн |
Способ модулирования роста гематопоэтических стволовых клеток
|
|
PL2044056T3
(pl)
|
2006-07-14 |
2013-01-31 |
Novartis Ag |
Pochodne pirymidyny jako inhibitory ALK-5
|
|
CA2676044C
(en)
|
2007-01-30 |
2019-10-22 |
University Of Georgia Research Foundation, Inc. |
Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc)
|
|
SI2856876T1
(en)
|
2007-03-30 |
2018-04-30 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
|
|
WO2009091826A2
(en)
|
2008-01-14 |
2009-07-23 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car)
|
|
WO2009097140A1
(en)
|
2008-01-30 |
2009-08-06 |
Memorial Sloan-Kettering Cancer Center |
Methods for off -the -shelf tumor immunotherapy using allogeneic t-cell precursors
|
|
WO2009104825A1
(en)
*
|
2008-02-18 |
2009-08-27 |
Kaist |
Method for inducing the defferentiation of embryonic stem cells into hemangioblast
|
|
CA3186451A1
(en)
|
2008-05-06 |
2009-11-12 |
Astellas Institute For Regenerative Medicine |
Hemangio colony forming cells and non-engrafting hemangio cells
|
|
EP3623374B1
(en)
|
2008-12-03 |
2021-09-08 |
The Scripps Research Institute |
Stem cell cultures
|
|
WO2010087594A2
(ko)
|
2009-01-28 |
2010-08-05 |
한국생명공학연구원 |
시디９３ 또는 이의 가용성 단편의 용도
|
|
WO2010096746A1
(en)
*
|
2009-02-20 |
2010-08-26 |
Cellular Dynamics International, Inc. |
Methods and compositions for the differentiation of stem cells
|
|
KR101720961B1
(ko)
|
2009-02-27 |
2017-03-29 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
다능성 세포의 분화
|
|
EP2419511B1
(en)
|
2009-04-09 |
2018-01-17 |
Sangamo Therapeutics, Inc. |
Targeted integration into stem cells
|
|
CA2777720C
(en)
|
2009-10-16 |
2020-10-06 |
The Scripps Research Institute |
Induction of pluripotent cells
|
|
WO2011072246A2
(en)
|
2009-12-10 |
2011-06-16 |
Regents Of The University Of Minnesota |
Tal effector-mediated dna modification
|
|
US9206394B2
(en)
|
2010-02-03 |
2015-12-08 |
The University Of Tokyo |
Method for reconstructing immune function using pluripotent stem cells
|
|
JPWO2011096482A1
(ja)
*
|
2010-02-03 |
2013-06-13 |
国立大学法人 東京大学 |
多能性幹細胞を用いた免疫機能再建法
|
|
US8652845B2
(en)
|
2010-03-18 |
2014-02-18 |
Kyoto University |
Method for producing mesodermal cells by culturing under adherent conditions and without co-culture with cells from a different species in a serum-free medium
|
|
WO2011159726A2
(en)
|
2010-06-14 |
2011-12-22 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
|
WO2011159684A2
(en)
*
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
|
AU2011281062B2
(en)
|
2010-07-21 |
2015-01-22 |
Board Of Regents, The University Of Texas System |
Methods and compositions for modification of a HLA locus
|
|
US9279103B2
(en)
|
2010-08-05 |
2016-03-08 |
Wisconsin Alumni Research Foundation |
Simplified basic media for human pluripotent cell culture
|
|
ES2654994T3
(es)
|
2010-08-12 |
2018-02-15 |
Fate Therapeutics, Inc. |
Terapia mejorada con células madre y precursoras hematopoyéticas
|
|
US9181529B2
(en)
*
|
2010-10-19 |
2015-11-10 |
Cellular Dynamics International, Inc. |
Titration of differentiation medium components
|
|
BR112013014527A2
(pt)
|
2010-12-20 |
2017-03-07 |
Genentech Inc |
anticorpo isolado, ácido nucleico isolado, célula hospedeira, método para produzir um anticorpo, imunoconjugado, formulação farmacêutica, uso do imunoconjugado, método para tratamento de um indivíduo que tem um câncer positivo para mesotelina, para inibição de proliferação de uma célula positiva para mesotelina, para detecção de mesotelina humana em uma amostra biológica e para detectar um câncer positivo para mesotelina
|
|
EP2655601A4
(en)
|
2010-12-22 |
2014-09-10 |
Fate Therapeutics Inc |
CELL CULTURAL PLATFORM FOR INDIVIDUAL CELL SIZING AND IMPROVED RESOLUTION OF IPSCS
|
|
EP2658965B1
(en)
|
2010-12-31 |
2016-03-02 |
Universität für Bodenkultur Wien |
Method of generating induced pluripotent stem cells and differentiated cells
|
|
US8700106B2
(en)
|
2011-03-09 |
2014-04-15 |
Universal Electronics Inc. |
System and method for provision of infrared signalling in smart phone devices
|
|
CN102732483B
(zh)
|
2011-03-31 |
2014-12-03 |
北京大学 |
造血祖细胞的制备方法及其专用培养基
|
|
US20130071414A1
(en)
|
2011-04-27 |
2013-03-21 |
Gianpietro Dotti |
Engineered cd19-specific t lymphocytes that coexpress il-15 and an inducible caspase-9 based suicide gene for the treatment of b-cell malignancies
|
|
JP2014520551A
(ja)
|
2011-07-11 |
2014-08-25 |
セルラー ダイナミクス インターナショナル， インコーポレイテッド |
細胞のリプログラミング方法およびゲノムの改変方法
|
|
JP5872041B2
(ja)
|
2011-08-16 |
2016-03-01 |
サムスン ライフ パブリック ウェルフェア ファンデーション |
幹細胞由来微小胞を含む神経生成促進用組成物
|
|
CN102329769B
(zh)
|
2011-09-28 |
2013-07-31 |
浙江大学 |
一种获得造血干细胞的方法
|
|
US10391126B2
(en)
|
2011-11-18 |
2019-08-27 |
Board Of Regents, The University Of Texas System |
CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
|
|
SG11201402502RA
(en)
|
2011-11-21 |
2015-01-29 |
Sunnybrook Res Inst |
Populations of hematopoietic progenitors and methods of enriching stem cells therefor
|
|
JP6220791B2
(ja)
|
2011-12-02 |
2017-10-25 |
フェイト セラピューティクス，インコーポレイテッド |
増強された幹細胞組成物
|
|
WO2013086029A1
(en)
|
2011-12-05 |
2013-06-13 |
Primorigen Biosciences Inc. |
Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof
|
|
EP2788476B1
(en)
|
2011-12-08 |
2019-05-22 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
|
EP2606884A1
(en)
|
2011-12-21 |
2013-06-26 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Inhibitors of notch signaling pathway and use thereof in treatment of cancers
|
|
US20150166969A1
(en)
|
2012-02-24 |
2015-06-18 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for the treatment of hemoglobinopathies
|
|
FI2838548T3
(fi)
|
2012-04-17 |
2023-10-02 |
Univ Washington Through Its Center For Commercialization |
HLA:n luokan II puutteelliset solut, HLA:n luokan II puutteelliset solut, jotka kykenevät ilmentämään HLA:n luokan II proteiineja, ja niiden käytöt
|
|
EP2839013B1
(en)
|
2012-04-18 |
2020-08-26 |
The Board of Trustees of the Leland Stanford Junior University |
Non-disruptive gene targeting
|
|
WO2013163171A1
(en)
|
2012-04-24 |
2013-10-31 |
Kaufman Dan S |
Method for developing natural killer cells from stem cells
|
|
JP6164746B2
(ja)
|
2012-05-22 |
2017-07-19 |
国立大学法人 東京大学 |
抗原特異的ｔ細胞の製造方法
|
|
BR112014029417B1
(pt)
|
2012-05-25 |
2023-03-07 |
Cellectis |
Método ex vivo para a preparação de células t para imunoterapia
|
|
WO2014011540A1
(en)
|
2012-07-09 |
2014-01-16 |
Emory University |
Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
|
|
MX370148B
(es)
|
2012-10-02 |
2019-12-03 |
Memorial Sloan Kettering Cancer Center |
Composiciones y su uso para inmunoterapia.
|
|
US20150329821A1
(en)
|
2012-10-19 |
2015-11-19 |
Agency For Science, Technology And Research |
Methods of differentiating stem cells into one or more cell lineages
|
|
US9382531B2
(en)
|
2012-10-22 |
2016-07-05 |
Wisconsin Alumni Research Foundation |
Induction of hemogenic endothelium from pluripotent stem cells
|
|
US9255250B2
(en)
|
2012-12-05 |
2016-02-09 |
Sangamo Bioscience, Inc. |
Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene
|
|
CA2896053A1
(en)
|
2012-12-21 |
2014-06-26 |
Ocata Therapeutics, Inc. |
Methods for production of platelets from pluripotent stem cells and compositions thereof
|
|
HUE043785T2
(hu)
|
2013-03-13 |
2019-09-30 |
Wisconsin Alumni Res Found |
Módszerek és anyagok humán pluripotens õssejtek hematoendothelialis differenciálására meghatározott körülmények között
|
|
IL311390A
(en)
|
2013-03-15 |
2024-05-01 |
Memorial Sloan Kettering Cancer Center |
Preparations and methods for immunotherapy
|
|
US9943545B2
(en)
|
2013-03-15 |
2018-04-17 |
Fate Therapeutics, Inc. |
Stem cell culture media and methods of enhancing cell survival
|
|
WO2014165707A2
(en)
|
2013-04-03 |
2014-10-09 |
Memorial Sloan-Kettering Cancer Center |
Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
|
|
EP4286517A3
(en)
|
2013-04-04 |
2024-03-13 |
President and Fellows of Harvard College |
Therapeutic uses of genome editing with crispr/cas systems
|
|
US10117899B2
(en)
|
2013-10-17 |
2018-11-06 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
|
|
US9932607B2
(en)
|
2013-11-15 |
2018-04-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Site-specific integration of transgenes into human cells
|
|
CA2941004A1
(en)
|
2014-03-04 |
2015-09-11 |
Peter Flynn |
Improved reprogramming methods and cell culture platforms
|
|
PT3122769T
(pt)
|
2014-03-28 |
2023-04-24 |
Univ Minnesota |
Polipéptidos, células e métodos que envolvem cd16 manipulado
|
|
KR20200138445A
(ko)
|
2014-04-24 |
2020-12-09 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
입양 세포 요법 생성물을 생성하기 위한 유도 만능 줄기 세포의 응용
|
|
CN103937743B
(zh)
|
2014-04-27 |
2017-12-01 |
浙江大学 |
一种利用三维诱导系统获得造血干细胞的方法
|
|
WO2016123100A1
(en)
|
2015-01-26 |
2016-08-04 |
Fate Therapeutics, Inc. |
Methods and compositions for inducing hematopoietic cell differentiation
|
|
US20180112180A1
(en)
|
2015-01-26 |
2018-04-26 |
Fate Therapeutics, Inc. |
Cells with increased immuno-regulatory properties and methods for their use and manufacture
|
|
US20170020922A1
(en)
|
2015-07-16 |
2017-01-26 |
Batu Biologics Inc. |
Gene editing for immunological destruction of neoplasia
|
|
JP6816133B2
(ja)
|
2015-10-05 |
2021-01-20 |
プレシジョン バイオサイエンシズ，インク． |
改変ヒトｔ細胞受容体アルファ定常領域遺伝子を含む遺伝子改変細胞
|
|
SG11201803145RA
(en)
|
2015-11-04 |
2018-05-30 |
Fate Therapeutics Inc |
Methods and compositions for inducing hematopoietic cell differentiation
|
|
KR20250141836A
(ko)
|
2015-11-04 |
2025-09-29 |
페이트 세러퓨틱스, 인코포레이티드 |
만능 세포의 유전자 조작
|
|
WO2017164257A1
(ja)
|
2016-03-23 |
2017-09-28 |
国立大学法人京都大学 |
血球分化能の高い中胚葉誘導方法
|
|
EP4628587A3
(en)
|
2016-04-15 |
2026-02-25 |
Memorial Sloan Kettering Cancer Center |
Transgenic t cell and chimeric antigen receptor t cell compositions and related methods
|